SE9302013D0 - Foerfarande foer bestaemning av hba 1c och komposition foer genomfoerandet av foerfarandet - Google Patents

Foerfarande foer bestaemning av hba 1c och komposition foer genomfoerandet av foerfarandet

Info

Publication number
SE9302013D0
SE9302013D0 SE9302013A SE9302013A SE9302013D0 SE 9302013 D0 SE9302013 D0 SE 9302013D0 SE 9302013 A SE9302013 A SE 9302013A SE 9302013 A SE9302013 A SE 9302013A SE 9302013 D0 SE9302013 D0 SE 9302013D0
Authority
SE
Sweden
Prior art keywords
procedure
hba
determination
composition before
before implementation
Prior art date
Application number
SE9302013A
Other languages
English (en)
Other versions
SE9302013L (sv
SE504914C2 (sv
Inventor
O *Jeppsson Jan
Original Assignee
Boehringer Mannheim Scandinavia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Scandinavia Ab filed Critical Boehringer Mannheim Scandinavia Ab
Priority to SE9302013A priority Critical patent/SE504914C2/sv
Publication of SE9302013D0 publication Critical patent/SE9302013D0/sv
Priority to AU70123/94A priority patent/AU7012394A/en
Priority to PCT/SE1994/000564 priority patent/WO1994029730A1/en
Publication of SE9302013L publication Critical patent/SE9302013L/sv
Publication of SE504914C2 publication Critical patent/SE504914C2/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE9302013A 1993-06-11 1993-06-11 Förfarande för bestämning av HbA1C och komposition för genomförandet av förfarandet SE504914C2 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9302013A SE504914C2 (sv) 1993-06-11 1993-06-11 Förfarande för bestämning av HbA1C och komposition för genomförandet av förfarandet
AU70123/94A AU7012394A (en) 1993-06-11 1994-06-10 Method for determining hba1c, and composition for implementing the method
PCT/SE1994/000564 WO1994029730A1 (en) 1993-06-11 1994-06-10 METHOD FOR DETERMINING HbA1c, AND COMPOSITION FOR IMPLEMENTING THE METHOD

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9302013A SE504914C2 (sv) 1993-06-11 1993-06-11 Förfarande för bestämning av HbA1C och komposition för genomförandet av förfarandet

Publications (3)

Publication Number Publication Date
SE9302013D0 true SE9302013D0 (sv) 1993-06-11
SE9302013L SE9302013L (sv) 1994-12-12
SE504914C2 SE504914C2 (sv) 1997-05-26

Family

ID=20390247

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9302013A SE504914C2 (sv) 1993-06-11 1993-06-11 Förfarande för bestämning av HbA1C och komposition för genomförandet av förfarandet

Country Status (3)

Country Link
AU (1) AU7012394A (sv)
SE (1) SE504914C2 (sv)
WO (1) WO1994029730A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2356343T3 (es) * 2005-05-20 2011-04-07 Germediq Forschungs- Und Entwicklungsgesellschaft Mbh Método para la determinación de factores de riesgo cardiovasculares en sangre desecada.
CN106033076A (zh) * 2015-03-18 2016-10-19 杭州量康科技有限公司 用于检测干血样本的方法以及***

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045529A (en) * 1989-03-27 1991-09-03 Bionostics, Inc. Tonometric fluid for blood gas and co-oximetry instruments

Also Published As

Publication number Publication date
SE9302013L (sv) 1994-12-12
AU7012394A (en) 1995-01-03
WO1994029730A1 (en) 1994-12-22
SE504914C2 (sv) 1997-05-26

Similar Documents

Publication Publication Date Title
DE69434497D1 (de) Verwendung von alpha-1,4-glukanlyase zur herstellung von 1,5 d-anhydrofruktose
DE69527959D1 (de) Nachweis von Retikulozyten mit Coriphosphin O
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
EA199900725A1 (ru) Синергетические комбинации сульфонилмочевины и глитазона при лечении диабета
DK502189A (da) Forbedringer ved eller vedroerende antistoffer
ES2073390T3 (es) Homologos de aprotinina preparados por tecnologia genetica.
DK322188D0 (da) Fremgangsmaade til fremstilling af protein
DE59109048D1 (de) Inhibitoren zur antikoagulierenden Vorbehandung von Blutproben
DK0506658T3 (da) Sammensætninger og fremgangsmåde til behandling af smertefulde, inflammatoriske eller allergiske lidelser
DK175383A (da) Fremgangsmaade til bestemmelse af low density lipoproteiner (ldl) og reagens til gennemfoerelse af fremgangsmaaden
PT94633A (pt) Metodo para a desnaturacao oxidante de analitos de proteina
DE69119656D1 (de) Satz zur spezifischen Bestimmung von Angiotensin-II
KR840008287A (ko) B형 간염 바이러스 표면항원의 정제방법
ATE134231T1 (de) Verbesserung beim bleichen von pulpe
SE9302013D0 (sv) Foerfarande foer bestaemning av hba 1c och komposition foer genomfoerandet av foerfarandet
SE7904282L (sv) Forfarande for detektering av rispor i provkroppar
DK327183D0 (da) Fremgangsmade til udfoerelse af elektromikrobiel reduktion
DE3474358D1 (en) Method of decreasing turbidity in control sera
ES2061744T3 (es) Inmunogeno y su aplicacion para la obtencion de anticuerpos especificos contra hba1c.
AU4172289A (en) Wood preservative composition and method of treating wood with same
EP0359281A3 (en) Silver staining technique and kit
KR890008313A (ko) 안티 pci모노클론 항체
KR950704514A (ko) 가죽의 카세인 가공방법(method for casein finishing of leather)
ES2113872T3 (es) Composiciones de tampones y procedimiento para su preparacion.
ES2089132T3 (es) Analisis de pelo.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 9302013-9

Format of ref document f/p: F